Ontology highlight
ABSTRACT:
SUBMITTER: Loupakis F
PROVIDER: S-EPMC7607787 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Therapeutic advances in medical oncology 20201031
Over the past 20 years, management of patients with metastatic colorectal cancer (mCRC) has improved considerably, leading to increased overall survival and more patients eligible for third- or later-line therapy. Currently, two oral therapies are recommended in the third-line treatment of mCRC, regorafenib and trifluridine/tipiracil. Selecting the most appropriate treatment in the third-line setting poses different challenges compared with treatment selection at earlier stages. Therefore, it is ...[more]